Tags

Type your tag names separated by a space and hit enter

Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?
Expert Opin Drug Saf. 2020 10; 19(10):1367-1369.EO

Authors+Show Affiliations

Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.

Pub Type(s)

Journal Article
Comment

Language

eng

PubMed ID

32840116

Citation

Raschi, Emanuel, et al. "Baricitinib, JAK Inhibitors and Liver Injury: a Cause for Concern in COVID-19?" Expert Opinion On Drug Safety, vol. 19, no. 10, 2020, pp. 1367-1369.
Raschi E, Caraceni P, Poluzzi E, et al. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? Expert Opin Drug Saf. 2020;19(10):1367-1369.
Raschi, E., Caraceni, P., Poluzzi, E., & De Ponti, F. (2020). Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? Expert Opinion On Drug Safety, 19(10), 1367-1369. https://doi.org/10.1080/14740338.2020.1812191
Raschi E, et al. Baricitinib, JAK Inhibitors and Liver Injury: a Cause for Concern in COVID-19. Expert Opin Drug Saf. 2020;19(10):1367-1369. PubMed PMID: 32840116.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19? AU - Raschi,Emanuel, AU - Caraceni,Paolo, AU - Poluzzi,Elisabetta, AU - De Ponti,Fabrizio, Y1 - 2020/08/25/ PY - 2020/8/26/pubmed PY - 2020/10/28/medline PY - 2020/8/26/entrez SP - 1367 EP - 1369 JF - Expert opinion on drug safety JO - Expert Opin Drug Saf VL - 19 IS - 10 SN - 1744-764X UR - https://www.unboundmedicine.com/medline/citation/32840116/Baricitinib_JAK_inhibitors_and_liver_injury:_a_cause_for_concern_in_COVID_19 L2 - https://www.tandfonline.com/doi/full/10.1080/14740338.2020.1812191 DB - PRIME DP - Unbound Medicine ER -